It is implicated in degrading the TSC1 and TSC2 complex, which is a critical negative regulator of the mammalian target of rapamycin complex1 (mTORC1), promoting HCC progression by over-activating mTORC1 signaling (Guo et al., 2018). Here, TSC2 is linked to hepatocellular carcinoma.